PANoptosis, a lytic cell death pathway, is promising for cancer immunotherapy, yet its therapeutic exploitation is underdeveloped. Here, the authors report a tumor-targeting nanozyme, Hemin-His-Mn, that concurrently activates retinoic acid-inducible gene I (RIG-I)–mediated PANoptosome assembly and catalyzes reactive oxygen species amplification to achieve PANoptosis induction.
- Shuohui Dong
- Ye Yuan
- Lei Chen